Hypertrichosis of the eyelashes caused by bimatoprost.
The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.
Tosti
Antonella
A
Department of Dermatology, University of Bologna, Italy. tosti@med.unibo.it
Pazzaglia
Massimiliano
M
Voudouris
Stylianos
S
Tosti
Giovanni
G
D000368:Aged; D000577:Amides; D000959:Antihypertensive Agents / Q000009:adverse effects*; D000069580:Bimatoprost; D003008:Cloprostenol / Q000031:analogs & derivatives; D005140:Eyelashes; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D008055:Lipids / Q000009:adverse effects*
D000577:Amides; D000959:Antihypertensive Agents; D008055:Lipids; D003008:Cloprostenol; D000069580:Bimatoprost